Embarking on a disruptive way to treat Multiple Sclerosis and other serious immune diseases
Isabelle Ote and Valérie Barette, Project Leaders at Belgian immunotherapy expert Imcyse, discuss its next phase of growth, and how to apply ImotopeTM technology to the treatment of MS.
Public health response to dementia
Chris Lynch, Deputy CEO at Alzheimer’s Disease International, sheds light on the WHO Global action plan on the public health response to dementia 2017-2025.
What is Osteogenesis Imperfecta (OI)?
Patricia Osborne, Chief Executive of the Brittle Bone Society, tells us what we need to know about Osteogenesis Imperfecta.
Patient and Public Involvement at the heart of brain research
Professor Mogens Hørder, PPI expert, JPND’s management board member and representative of member state Denmark, discusses how Patient and Public Involvement (PPI) is at the heart of neurodegenerative disease research.
More must be done to tackle diabetes
Professor Andrew Boulton, President & Professor Akhtar Hussain, President-Elect of the International Diabetes Federation, argue that while there has been a century of saving lives, more must be done to tackle diabetes.
Organ transplants fell by a third during first wave of COVID-19
Organ transplants performed during the first wave of COVID-19 fell by a third compared to 2019, according to a new study.
Malaria deaths reduced by 70% with vaccine and drug combination
A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.
Supporting families living with Huntington’s Disease
Chief Executive of the Huntington’s Disease Association, Cath Stanley, maps out the charities ongoing work to support its community, despite the COVID-19 pandemic.
Immunocompromised patients show low immune response after second vaccine
According to the OCTAVE study, immunocompromised patients presented low immune responses after two doses of the same COVID-19 vaccine.
Investing in the future of neuroscience
Nina Schor, Deputy Director and Acting Scientific Director of NINDS, underlines the importance of investing in the future of neuroscience.
The priorities for future stroke research
Richard Francis, Head of Research at the Stroke Association, identifies the priority areas for research investment that will make the greatest difference to stroke survivors.
A changing landscape for type 1 diabetes
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, charts a changing landscape for type 1 diabetes.
A different view of cardiovascular hæmodynamics
Here, Professors Nigel Shrive and John Tyberg illustrate how their work has led to an alternative interpretation of hæmodynamics compared to the paradigm that was proposed over 60 years ago.
NHS GP says long COVID patients “shouldn’t suffer in silence”
NHS GP and lead GP at Numan, Dr Luke Pratsides tells us everything he knows about the symptoms of long COVID and what’s being done to tackle this novel disease.
New mosquito control tools are critical
Leo Braack, Malaria Consortium’s Senior Vector Control Specialist, recounts the ongoing battle against vector-borne diseases and shares why the need for new mosquito control tools has become critical.
Myopia management: Looking after the “other” pandemic
Max Halford FBCO CL, Clinical Lead at Association of British Dispensing Opticians, turns our thoughts towards the “other” pandemic, myopia management.
Using human models of brain development to understand autism
Dr Kristen Kroll from Washington University School of Medicine discusses new approaches for studying autism and other neurodevelopmental disorders by using human cellular models of brain development.
COVID-19 reveals the underappreciated burden of smell disorders
Chrissi Kelly, Founder of the charity AbScent, explains that COVID-19 reveals the underappreciated burden of smell disorders.
Hormones contribute to movement impairment after brain injury
Hormones released after a brain injury contribute to movement problems on the left and right sides of the body, according to a new study.
Black liver transplant patients have lower survival rates than white or Hispanic patients
Black recipients of liver transplants have lower post-transplant survival rates than white or Hispanic patients, according to a new study from Keck Medicine of USC.
